替代结合蛋白走向成熟：与抗体竞争 - Suppr

Suppr

超能文献

Alternative binding proteins get mature: rivalling antibodies.

作者信息

Kolmar Harald, Skerra Arne

机构信息

Clemens Schöpf Institut für Biochemie,Technische Universität Darmstadt, Germany.

出版信息

FEBS J. 2008 Jun;275(11):2667. doi: 10.1111/j.1742-4658.2008.06437.x. Epub 2008 Apr 24.

DOI:10.1111/j.1742-4658.2008.06437.x

PMID:18435760

Abstract

摘要

相似文献

Alternative binding proteins get mature: rivalling antibodies.

FEBS J. 2008 Jun;275(11):2667. doi: 10.1111/j.1742-4658.2008.06437.x. Epub 2008 Apr 24.

Proteins emerge from disarray.

Nat Biotechnol. 2000 Sep;18(9):932-3. doi: 10.1038/79400.

A method for the reversible trapping of proteins in non-native conformations.

Biochemistry. 2008 Dec 23;47(51):13620-34. doi: 10.1021/bi801362f.

Terminal assembly of sarcomeric filaments by intermolecular beta-sheet formation.

Trends Biochem Sci. 2009 Jan;34(1):33-9. doi: 10.1016/j.tibs.2008.09.009. Epub 2008 Nov 6.

Biotechnology and Applied Biochemistry. Editorial.

Biotechnol Appl Biochem. 2011 Jan-Feb;58(1):1. doi: 10.1002/bab.14.

Hitting the sweet spot.

Nat Biotechnol. 2002 Mar;20(3):234-5. doi: 10.1038/nbt0302-234.

[Immunoproteins].

Tanpakushitsu Kakusan Koso. 1994 May;39(7):1176-83.

Bringing picomolar protein detection into proximity.

Nat Biotechnol. 2002 May;20(5):448-9. doi: 10.1038/nbt0502-448.

A protein-stabilizing technology for enhanced antibody stability and antibody-binding profiles in a microchip array.

Biotechnol J. 2012 Aug;7(8):1002-7. doi: 10.1002/biot.201100494. Epub 2012 Apr 27.

Plastic antibodies: developments and applications.

Trends Biotechnol. 1998 Nov;16(11):468-75. doi: 10.1016/s0167-7799(98)01222-0.

引用本文的文献

The reduced form of the antibody CH2 domain.

Protein Sci. 2021 Sep;30(9):1895-1903. doi: 10.1002/pro.4142. Epub 2021 Jun 16.

Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.

Biochem J. 2019 Jan 11;476(1):67-83. doi: 10.1042/BCJ20180792.

Expression, purification, and characterization of engineered antibody CH2 and VH domains.

Methods Mol Biol. 2012;899:85-102. doi: 10.1007/978-1-61779-921-1_6.

Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery.

Curr Pharm Des. 2011 Dec;17(38):4294-307. doi: 10.2174/138161211798999438.

Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor.

J Biol Chem. 2011 Aug 5;286(31):27288-93. doi: 10.1074/jbc.M111.254219. Epub 2011 Jun 13.

Protein microarrays: novel developments and applications.

Pharm Res. 2011 Jul;28(7):1480-99. doi: 10.1007/s11095-010-0325-1. Epub 2010 Nov 30.

Cyclotides, a promising molecular scaffold for peptide-based therapeutics.

Biopolymers. 2010;94(5):611-6. doi: 10.1002/bip.21433.

Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variant.

Protein Eng Des Sel. 2010 May;23(5):403-13. doi: 10.1093/protein/gzq012. Epub 2010 Feb 23.

Engineered CH2 domains (nanoantibodies).

MAbs. 2009 Jan-Feb;1(1):26-8. doi: 10.4161/mabs.1.1.7480.

A large human domain antibody library combining heavy and light chain CDR3 diversity.

Mol Immunol. 2010 Jan;47(4):912-21. doi: 10.1016/j.molimm.2009.09.039. Epub 2009 Nov 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Alternative binding proteins get mature: rivalling antibodies.

FEBS J. 2008 Jun;275(11):2667. doi: 10.1111/j.1742-4658.2008.06437.x. Epub 2008 Apr 24.

Proteins emerge from disarray.

Nat Biotechnol. 2000 Sep;18(9):932-3. doi: 10.1038/79400.

A method for the reversible trapping of proteins in non-native conformations.

Biochemistry. 2008 Dec 23;47(51):13620-34. doi: 10.1021/bi801362f.

Terminal assembly of sarcomeric filaments by intermolecular beta-sheet formation.

Trends Biochem Sci. 2009 Jan;34(1):33-9. doi: 10.1016/j.tibs.2008.09.009. Epub 2008 Nov 6.

Biotechnology and Applied Biochemistry. Editorial.

Biotechnol Appl Biochem. 2011 Jan-Feb;58(1):1. doi: 10.1002/bab.14.

Hitting the sweet spot.

Nat Biotechnol. 2002 Mar;20(3):234-5. doi: 10.1038/nbt0302-234.

[Immunoproteins].

Tanpakushitsu Kakusan Koso. 1994 May;39(7):1176-83.

Bringing picomolar protein detection into proximity.

Nat Biotechnol. 2002 May;20(5):448-9. doi: 10.1038/nbt0502-448.

A protein-stabilizing technology for enhanced antibody stability and antibody-binding profiles in a microchip array.

Biotechnol J. 2012 Aug;7(8):1002-7. doi: 10.1002/biot.201100494. Epub 2012 Apr 27.

Plastic antibodies: developments and applications.

Trends Biotechnol. 1998 Nov;16(11):468-75. doi: 10.1016/s0167-7799(98)01222-0.

引用本文的文献

The reduced form of the antibody CH2 domain.

Protein Sci. 2021 Sep;30(9):1895-1903. doi: 10.1002/pro.4142. Epub 2021 Jun 16.

Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.

Biochem J. 2019 Jan 11;476(1):67-83. doi: 10.1042/BCJ20180792.

Expression, purification, and characterization of engineered antibody CH2 and VH domains.

Methods Mol Biol. 2012;899:85-102. doi: 10.1007/978-1-61779-921-1_6.

Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery.

Curr Pharm Des. 2011 Dec;17(38):4294-307. doi: 10.2174/138161211798999438.

Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor.

J Biol Chem. 2011 Aug 5;286(31):27288-93. doi: 10.1074/jbc.M111.254219. Epub 2011 Jun 13.

Protein microarrays: novel developments and applications.

Pharm Res. 2011 Jul;28(7):1480-99. doi: 10.1007/s11095-010-0325-1. Epub 2010 Nov 30.

Cyclotides, a promising molecular scaffold for peptide-based therapeutics.

Biopolymers. 2010;94(5):611-6. doi: 10.1002/bip.21433.

Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variant.

Protein Eng Des Sel. 2010 May;23(5):403-13. doi: 10.1093/protein/gzq012. Epub 2010 Feb 23.

Engineered CH2 domains (nanoantibodies).

MAbs. 2009 Jan-Feb;1(1):26-8. doi: 10.4161/mabs.1.1.7480.

A large human domain antibody library combining heavy and light chain CDR3 diversity.

Mol Immunol. 2010 Jan;47(4):912-21. doi: 10.1016/j.molimm.2009.09.039. Epub 2009 Nov 1.